Orphan drug commercialization is maturing
Existing incentives continue to draw in new drug developers; payers begin to look at competitive markets to drive down drug costs
Uncertainty around the pediatric priority review voucher (PRV) program
Advancing the biopharma cold chain
Vendors and service providers scramble to serve a growing market
Using near real-time medical claims to target physicians with newly diagnosed patients
A conversation with Gerry Gleeson, Walgreens Specialty Pharmacy
Since 1841: The Story of an Enduring Family Business
Morris & Dickson publishes a family and company history
Specialty drug market access reality check
Ten payer pressures to act on now
Moving From Big Pharma To A Small Company? You May Be In For A Few Surprises
Sponsored by TGaS Advisors
Mylan will create a generic EpiPen, competing against itself
More unusual gyrations as Mylan attempts to quell uprising against its pricing policies
J.D. Power pharmacy satisfaction survey: independents on top in brick-and-mortar
Good Neighbor and Health Mart franchises trade top positions
Mylan’s EpiPen re-energizes drug pricing disputes
Presidential politicking adds momentum to the growing backlash, and not just for Mylan
Big data analytics is a work in progress in pharma
Substantial investments have been made, but beneficial results hard to identify, says ZS Associates
Attaining 'commercial agility' in data management
Life sciences marketers contend with a flood of new data sources—and the challenge of integrating them for meaningful results
MannKind calls on Asembia to assist in relaunch of Afreeza inhalable insulin
Applying specialty-pharma techniques to a potentially mass-market drug
More capacity and resources for clinical trial logistics
World Courier, Marken and QuickSTAT expand geographical reach
Sonoco ThermoSafe offers cold chain training—with an academic contribution
Company pairs up with Clemson University professor for online and in-person training
Open-SCS group gains momentum for industry-wide serialization data standard
Vendors and users come together to standardize communication protocols
Where are those missing billions in new-product pharma sales?
Healthcare research firm calls out the alarmist predictions over PCSK9s and other new drugs
Guilty verdict is handed down in 2012 MOMS Pharmacy drug-diversion case
‘Operation Black Market Meds’ involved New York State, Florida and federal investigators
PPD snaps up Evidera, deepening services in real-world evidence
CROs are expanding their scope of services
Ocean transportation for life sciences: More reliable, more cost-effective
Advanced engineering brings powered, active control of temperature-sensitive shipments via ocean containers
Generics distributor Anda, Inc. has a new owner: Teva Pharma
Deal deepens Teva’s business in generics
A 30% capacity expansion at Sharp Packaging
Company invests $45 million for serialization- and cold-chain-ready capacity
New Zika virus test—and a map of ‘Zika zones’
While CDC steps up its analysis, private companies race to commercialize tests, vaccines and tracking mechanisms
Private-capital injection into inVentiv Health reshuffles life sciences outsourcing
Advent joins Thomas Lee Partners in ownership of the clinical, commercial outsourcer
A fake drugs intrusion in the US—with a twist
Painkiller addicts buy street drugs that simulate well-known pharma brands
Pharma company runs afoul of child-resistant packaging rules
Consumer Products Safety Commission steps into distribution of a generic form of Ambien
Take a survey--help the industry understand cold chain trends
Cold Chain Technologies looks into shipping practices
UPS steps into clinical trial materials management
Emphasis is on cold chain capabilities, dedicated global network
A jurisdictional battle breaks out over physician assistant certification
AAPA is positioning itself to provide alternative certification
